Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Cucurbitacin I Workflows for STAT3 Research
2026-08-27
Cucurbitacin I, also known as JSI-124, supports pathway-proximal studies of STAT3 phosphorylation, transcriptional activity, apoptosis, invasion, and treatment response. This guide converts its reported activity into practical workflows while using a human SAN-plexus assembloid study as a disciplined model for choosing layered, maturation-aware assays.
-
1-methyl Adenosine: Assay Workflows & Uses
2026-08-27
Learn how to use 1-methyl Adenosine as a mechanistic probe, analytical reference, and biomarker-focused assay component. This workflow connects controlled cell exposure with isomer-resolved UHPLC–MS/MS, matrix cleanup, and practical troubleshooting for RNA modification research and cancer metabolism studies.
-
EdU Imaging Kits (488) for Scalable EV Research
2026-08-26
Use EdU Imaging Kits (488) to track S-phase entry during induced MSC expansion and to test how extracellular vesicles influence repair-relevant cell responses. The workflow combines sensitive click-chemistry labeling with microscopy or flow cytometry, providing a practical proliferation readout alongside scalable EV manufacturing studies.
-
2'3'-cGAMP: From STING Activation to Translation
2026-08-26
A mechanistic and translational perspective on 2'3'-cGAMP (sodium salt), linking cGAS-STING signaling, endothelial STING-JAK1 biology, experimental validation, and strategic immunotherapy research.
-
GIGYF2, STAU1, and Hepatic Insulin Resistance
2026-08-25
The reference study identifies GIGYF2 as an RNA-binding regulator of obesity-related hepatic insulin resistance and defines a GIGYF2–STAU1–PTEN pathway that suppresses PI3K/AKT signaling. By combining 2-NBDG-based glucose uptake measurements, molecular perturbation, RNA immunoprecipitation, and high-fat-diet mouse experiments, the work connects altered RNA regulation with impaired hepatic glucose handling.
-
Carrier-Platin and the ROS Storm in Cancer Cells
2026-08-25
Liu et al. describe carrier-platin, a platinum nanotherapeutic that confines ultrasmall platinum-based nanoparticles within a poly(amino acids) carrier to generate a rapid intracellular ROS burst. The resulting cancer-cell death occurs independently of DNA damage and is distinct from canonical apoptosis and ferroptosis, suggesting a strategy for addressing platinum resistance while limiting systemic toxicity.
-
2-NBDG for Cellular Glucose Uptake Assays
2026-08-24
2-NBDG converts transporter-mediated glucose uptake into a measurable fluorescent signal for flow cytometry, microscopy, and plate-based profiling. This practical guide shows how to connect that readout to HK2-centered metabolic mechanisms, including the arsenic-induced Warburg phenotype reported in human L-02 hepatocytes.
-
Dynamic LRIG1 Expression in Salivary Gland Development
2026-08-24
Liu and colleagues combine single-cell RNA sequencing with qRT-PCR, immunofluorescence, and RNAscope to define how Lrig1 expression changes during murine submandibular gland development. Their results place LRIG1 in epithelial and mesenchymal compartments, with notable enrichment in acinar and basal progenitor-associated populations, while complementary human cell-line experiments examine possible effects on proliferation, migration, and transcriptional regulation.
-
EdU Imaging Kits (Cy3) for Organoid S-Phase Mapping
2026-08-23
EdU Imaging Kits (Cy3) provide precise 5-ethynyl-2'-deoxyuridine imaging kit performance for mapping S-phase DNA synthesis in complex organoids. This guide explains how to convert EdU fluorescence into a spatially informed interpretation of CAF-mediated drug response.
-
MG-262 Proteasome Inhibition Workflows
2026-08-22
MG-262 enables reversible, cell-permeable proteasome perturbation for linking ubiquitin accumulation with inflammation, cell-cycle arrest, and apoptosis. This workflow translates pulmonary epithelial findings into practical assay designs while highlighting dose, timing, washout, and matrix-specific controls.
-
DEV VP26, Actin–Myosin II, and Viral Proliferation
2026-08-22
Chen and colleagues combine VP26 interactome profiling with genetic and pharmacological perturbation to identify the host actin–myosin II network as a regulator of duck enteritis virus proliferation. The study highlights MYH9 as a candidate host factor and provides a framework for testing how cytoskeletal organization influences herpesvirus infection.
-
JNJ-26481585 (Quisinostat) in Cancer Research
2026-08-21
JNJ-26481585, also called Quisinostat, is a second-generation HDAC inhibitor and epigenetic modulator with strong reported activity against class I HDAC enzymes. Product data and a 2025 pituitary adenoma study support its use as a research tool for histone acetylation, apoptosis, cell proliferation assays, TRIM21 biology, and tumor growth inhibition.
-
Substrate Stiffness Drives Dentinogenesis via MEK1/2
2026-08-20
This study identifies a LAMB1–FAK–MEK1/2 signaling axis that connects substrate stiffness with odontoblast-like cell spreading and dentinogenic differentiation. Its findings provide a mechanistic framework for designing dental biomaterials in which cell–material mechanics are treated as active regulators of reparative dentin formation.
-
EZ Cap™ Cy5 EGFP mRNA for LNP Assays
2026-08-20
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) separates delivery from translation in one experiment by pairing Cy5 cargo tracking with EGFP protein expression. This dual-readout design helps researchers compare lipid nanoparticles, optimize difficult cell models, and diagnose whether assay failure occurs during uptake, intracellular trafficking, or protein production.
-
Tetrazolium (chloride) for Viability & Stroke Assays
2026-08-19
Use Tetrazolium (chloride) to convert dehydrogenase activity into a red, spatially resolved formazan signal for cell and ischemic-tissue studies. Its strongest use-case is pairing rapid cellular screening with ex vivo lesion mapping, while orthogonal assays prevent metabolic activity from being mistaken for absolute viability.